Invest – Environmental Genome

How the Environmental Genome Initiative Generates Superior Long Term Value

The nonprofit Environmental Genome Initiative is collaborating with product manufacturers and industry associations, government and intergovernmental agencies, foundations and investors to map the content, design, manufacturing processes and energy use of the 100,000 industrial chemicals-in-commerce used to make virtually all materials and products worldwide.

We are well positioned with a value-enhancing, open source business model that we believe will provide a clear path for outstanding returns. As policymakers and investors in the U.S. and worldwide are moving to require that companies disclose their climate risk and greenhouse gas and chemical emissions, the EG is providing the data enabling accurate emissions measurements, publicly defensible disclosures of those impacts as well as product, process and supply chain modifications for mitigation efforts.

The EG also provides the platform for research into a wider range of emissions that impact public health and safety, led by the significant role that environmental pollutants play in causing chronic diseases. This work is lending valuable new insights for , epidemiologists, pharmaceutical, medical and other life science researchers. We believe it will yield other large, unforeseen health benefits and lead to mass innovation, just as mapping the human genome enabled.

Product Fit with a Global Marketplace

The movement toward government-mandated disclosures of climate risk and greenhouse gas emissions worldwide will impact pubic companies, and inevitably their suppliers. Some countries, particularly in Europe, are pressing ahead with requirements for labelling on products sold there stating they meet safety, health, and environmental protection requirements. Regulators, investors and companies are reliant on a life cycle industry with datasets still in development. EG’s database is many times larger than its closest competitor.

Expansion Strategy

Central to our strategy is to go beyond global warming emissions, to assess a wider range of emissions that also impact public health and safety. That’s led by better understanding the significant role that pollutants play in causing chronic disease. The overlay of EG’s information with other data sets will also locate global geographic concentrations of specific chemical emissions, pinpoint population exposures and risks, and inform product, process and supply chain design changes that can improve the social determinants of health.

Investment Returns

The Environmental Genome is playing a major role in supporting climate risk disclosure and mitigation efforts and we believe it will yield many other societal health and safety benefits. We think EG’s open source model will fuel longterm growth while helping to keep operating costs low – delivering strong profitability and cashflow as well as superior returns for investors.

Proprietary Tool Development

The EG has developed proprietary search, visualization, reporting, life cycle modeling and chemical process modeling tools to support its ability to conduct detailed process evaluations that are core to improvement at the manufacturing plant level and the entire supply chain. EG has the most comprehensive environmental assessments available for credible Scope 3 disclosures.

Value Aligned Team

Our team has deep experience in chemical engineering, industrial engineering, human health science, and nonprofit management. Their industry experience includes the aviation, agriculture, building materials, energy, healthcare, pharmaceuticals, and textile sectors. Their work in green energy, product, process, and supply chain design; as well as global population exposures to chemicals informs our vision and our work.

Scalability

We’ve built on a well-developed system to map the 100,000 chemicals-in-commerce that are used to make all the materials and products used globally, tested it, and are focused on driving down the time and cost to map each one so that we can manage rapid growth.

Applications for the Environmental Genome Database

Compliance and Communications

Compliance with local, national and international environmental regulations
Carbon footprint
Environmental Product Declarations (EPDs)
Building certification
Health, safety and sustainability claims for customers, investors, and consumers
Product comparisons
Product labeling
Safety and risk assessments
Sustainable design concepts
Sustainable procurement
Water footprint

Manufacturing Analysis and Improvement

The EG’s methods are the next generation in the life cycle field, providing detailed estimated emissions and greenhouse gas intensity data and also supporting:

Analysis to facilitate technological innovation for energy and material conservation, improved processes, and product designs
Better manufacturing value chains
Lower costs due to pollution prevention, reduced water and carbon impacts and greater efficiencies

The database allows a variety of users from private and public enterprises, academic institutions, and NGOs globally to conduct research on the public health and safety impacts of emissions to air, water, and land and develop new life science applications.

Informs improvements in social determinants of health (SDOH) with manufacturing plant data on emissions and disability-adjusted life years (DALY).
Provides a better understanding of the relationship between pollutants and health, which is critical because epidemiologists attribute 70%-90% of chronic disease to the environment, of which pollutants are a major component.

Presentations, Articles and Reserch

List Title 1
List Title 2
List Title 3